Skip to main content
. 2022 Dec 1;10(4):118. doi: 10.3390/diseases10040118

Figure 13.

Figure 13

Proportion of patients who had symptomatic COVID-19 (TGM/CGM vs. comparator). CI, confidence interval; RR, risk ratio; TGM/CGM, tixagevimab/cilgavimab.